Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Incyte (INCY) -- Ignore unavailable to you. Want to Upgrade?

To: RCMac who wrote (1748)	4/26/2001 5:26:48 PM
From: nigel bates	Respond to of 3202

Encouraging that they have done a little more thinking, but where did they get the double digit idea from ? At the current price, I can't buy the "highly speculative" label, either. nig

To: RCMac who wrote (1748)	4/26/2001 8:38:48 PM
From: smh	Read Replies (1) \| Respond to of 3202

<Of course, Whitfield, who is refreshingly direct, says that this vision will only be validated when some of these drug candidates enter clinical trials. None has yet, so any putative royalties are at least six to ten years away.> An enlightened article given the Fool's longstanding position as chief jester in King Venter's court. Nonetheless, the above excerpt, is a perfect example of the fog that veils this company. <(ii) a few partners have told them to expect that they may be entering clinical trials in 2001, triggering royalty payments> Message 15285402 Now when did the first guy say the vision would be validated and when did the other guy say royalties might begin? Yes, I know milestones are only the tip of the... OH!... OH!... you mean there IS and iceberg?